跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 74 条关于
“NRFC”
全部
74
临床试验
40
药物
21
机构
1
资讯
12
去年
Australia's National Reconstruction Fund Invests $150M in Brandon Capital to Retain Biotech Innovation Onshore
去年
PolyActiva Secures $40M Series C to Advance Revolutionary Glaucoma Implant Technology
去年
Isatuximab-irfc (Sarclisa) Approved for Multiple Myeloma Treatment
2个月前
Oligodendrocyte NRF2 deficiency drives myelin pathology in age-related cognitive decline
10个月前
CRISPR Gene Editing Reverses Chemotherapy Resistance in Lung Cancer by Targeting NRF2
去年
MD Anderson Research Highlights: Modified NRF2 Activator, Canakinumab in MDS, and More
去年
Drug Hunter Highlights Key Pharmaceutical Patents and Clinical Updates from Late 2024
3个月前
NRF2's Dual Role in Ferroptosis: A Context-Dependent Switch for Cancer Therapy
去年
MD Anderson Highlights: Modified NRF2 Activator Reverses Chronic Pain, Canakinumab Shows Promise in MDS Subgroup
10个月前
Montai Therapeutics Advances First-in-Class Oral NRF2 Agonist for Ulcerative Colitis to IND-Enabling Studies
第 1 页,共 2 页
上一页
下一页